Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0002-9378(69)90072-6 | DOI Listing |
Taiwan J Obstet Gynecol
March 2024
Medipol University, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Turkey.
Objective: To test the hypothesis that paracervical block with 0.5 % bupivacaine decreases postoperative pain after total laparoscopic hysterectomy (TLH).
Materials And Method: This randomized double-blind placebo control trial included 152 women.
Gynecol Obstet Fertil Senol
January 2022
Service d'anesthesie réanimation médecine périopératoire, Université Paris, France Saclay, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France.
Obstet Gynecol Sci
January 2021
Minimally Invasive Unit, Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.
Objective: To study the efficacy and safety of 0.5% bupivacaine in paracervical block to reduce immediate postoperative pain after total laparoscopic hysterectomy.
Methods: A prospective, randomized, double-blind, placebo-controlled study was conducted at a tertiary referral center involving thirty women each in the treatment and placebo groups.
J Minim Invasive Gynecol
May 2020
Department of Obstetrics and Gynecology, University of Tennessee College of Medicine, Chattanooga, Tennessee (all authors).
Study Objective: To determine if performing a paracervical block with .5% bupivacaine before laparoscopic hysterectomy reduces postoperative pain.
Design: Double-blind randomized controlled trial (Canadian Task Force classification I).
JSLS
December 2018
Department of Obstetrics, Gynecology and Reproductive Science, Division of Gynecology.
Background And Objective: Some patients who undergo laparoscopic hysterectomy request overnight admission for pain management, thus increasing costs for a surgery that is safe for same-day discharge. We wanted to evaluate whether a paracervical block of bupivacaine with epinephrine before laparoscopic supracervical hysterectomy would decrease overnight admission rates, postoperative pain, and pain medication requirement.
Methods: This was a randomized, double-blind, placebo-controlled, parallel-group trial (Canadian Task Force classification I) at an academic medical center.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!